This bill aims to amend the Code of West Virginia by adding five new sections that mandate health insurance policies to cover biodentical hormones. Specifically, it requires that any insurer delivering or issuing group accident and sickness insurance, as well as health care corporations and health maintenance organizations, provide coverage for biodentical hormones when deemed medically necessary by a licensed physician. The coverage must be available to all subscribers and members and is contingent upon a thorough evaluation of the patient's symptoms, diagnostic test results, or response to treatment.

The new sections are designated as 33-15-4y, 33-16-3ii, 33-24-7z, 33-25-8w, and 33-25A-8z, and they collectively emphasize the importance of ensuring that patients have access to necessary hormone treatments. The bill specifies that this requirement will take effect for policies issued on or after January 1, 2026, thereby establishing a clear timeline for compliance by insurers in the state.

Statutes affected:
Introduced Version: 33-15-4y, 33-16-3ii, 33-24-7z, 33-25-8w, 33-25A-8z